News Focus
News Focus
icon url

Tuff-Stuff

05/09/13 6:51 AM

#508810 RE: Tuff-Stuff #508630

Isis Pharmaceuticals (ISIS) falls 2.5% premarket, adding to yesterday's double-digit losses after pricing its previously announced public offering at $19 per share, 3.4% below yesterday's close.